共 140 条
- [1] Adams JU(2008)Pharmacogenomics and personalized medicine Nat Educ 1 194-475
- [2] Aneesh T(2009)Pharmacogenomics: the right drug to the right person J Clin Med Res 1 191-1167
- [3] Sekhar S(2012)Pharmacogenomics and individualized medicine: translating science into practice Clin Pharmacol Ther 92 467-197
- [4] Jose A(2008)Economic advantage of pharmacogenomics-clinical trials with genetic information Stud Health Technol Inf 136 585-1514
- [5] Chandran L(2010)Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice Pharmacogenomics 11 1149-1207
- [6] Zachariah SM(2019)Roles of pharmacogenomics in non-anthracycline antineoplastic-induced cardiovascular toxicities: a systematic review and meta-analysis of genotypes effect Int J Cardiol 280 190-16
- [7] Crews KR(2001)Pharmacogenomics and dermatological therapeutics Arch Dermatol 137 1512-141
- [8] Hicks JK(2011)Role of pharmacogenomics in the management of traditional and novel oral anticoagulants Pharmacotherapy 31 1192-428
- [9] Pui CH(2001)Public opinion and regulation of the new human genetics The Human Genetics Commission, set up by the Government in 1999, was intended to bolster transparency surrounding decision-making in issues relating to the new human genetics Health Care Risk Rep 7 14-536
- [10] Relling MV(2009)Pharmacogenetics in Europe: barriers and opportunities Public Health Genomics 12 134-109